Belzutifan is usually a CYP2C19 substrate. Coadministration with CYP2C19 inhibitors may possibly enhance incidence or severity of adverse results. Check for anemia and hypoxia and decrease belzutifan dose as advised.Tic Issues: Constrained proof implies that every one CNS stimulants might exacerbate tics in people with pre-existing tic Problems. A … Read More